Chai, Peter R. http://orcid.org/0000-0003-0955-4117
Goodman, Georgia R.
Bronzi, Olivia
Gonzales, Gerard
Baez, Alejandro
Bustamante, Maria J.
Najarro, Jesse
Mohamed, Yassir
Sullivan, Matthew C.
Mayer, Kenneth H.
Boyer, Edward W.
O’Cleirigh, Conall
Rosen, Rochelle K.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Real-World User Experiences with a Digital Pill System to Measure PrEP Adherence: Perspectives from MSM with Substance Use
https://doi.org/10.1007/s10461-022-03594-9
Funding for this research was provided by:
National Institute on Drug Abuse (K23DA044874, R44DA051106, R01DA047236, R01DA047236)
National Institute of Allergy and Infectious Diseases (P30AI060354, P30AI060354)
Defense Advanced Research Projects Agency (HR001120S0041)
Bill and Melinda Gates Foundation (INV-002177)
Hans and mavis lopater psychosocial foundation
E-Ink Corporation
Gilead Sciences (ISR-17-10189)
Article History
Accepted: 15 January 2022
First Online: 28 January 2022
Declarations
:
: PRC is funded by NIH K23DA044874, R44DA051106 and research funding from Gilead Sciences (ISR-17-1018), Hans and Mavis Lopater Psychosocial Foundation, Defense Advanced Research Programs Agency and The Bill and Melinda Gates Foundation. KHM and CO are funded by NIAID P30AI060354. EWB and RKR are funded by NIH R01DA047236.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Fenway Community Health Institutional Review Board (protocol number 1087733).
Free to read: This content has been made available to all.